Citi Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $45

Moomoo NewsJan 10 06:34 ET · Ratings

Optimistic Growth Projections and Financial Adjustments Justify Buy Rating for BridgeBio Pharma

TipRanksJan 10 05:45 ET · Ratings

BridgeBio Pharma to Participate in the J.P. Morgan Healthcare Conference

BridgeBio PharmaJan 8 00:00 ET

BofA Securities Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $45

Moomoo NewsJan 6 06:31 ET · Ratings

S&P 500 Futures Drop In Premarket Trading; Sportradar Group, Cytokinetics Lead

Dow JonesDec 27, 2024 07:30 ET

BridgeBio Pharma Is Maintained at Outperform by Evercore ISI Group

Dow JonesDec 23, 2024 13:05 ET · Ratings